02268.HK
WuXi XDC Cayman Inc
HKSE · Healthcare · Medical - Diagnostics & Research · CN
HKD 72.80
−0.41%Margins
Gross margin
35.0%
EBITDA margin
29.5%
EBIT margin
26.7%
Net margin
23.9%
FCF margin
4.4%
25.4%
Return on equity
18.5%
Return on assets
27.1%
Return on invested capital
0.80x
Asset turnover
HKD 3.2B
Cash from operations
HKD 5.49
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026